Skip to main content

Find Clinical Trials

Home
Conditions
Stage III Renal Cell Cancer

Clinical trial condition

Stage III Renal Cell Cancer

Explore clinical trials studying Stage III Renal Cell Cancer. Study availability and eligibility vary by location and protocol.

31 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage III Renal Cell Cancer trial results

Completed

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

NCT01198184

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies

NCT01243359

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00354250

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00089362

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

NCT00182702

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00101114

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

NCT00060307

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

NCT00032188

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

NCT03682289

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +43 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

University of California, San Francisco San Francisco, California, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details